Sanjun Shi
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery 7
- Pharmaceutical Science top 2%
- Rehabilitation top 5%
- Wound Healing and Treatments 5
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics 9
- Molecular Medicine top 5%
-
- RNA Interference and Gene Delivery 14
- Advanced biosensing and bioanalysis techniques 11
-
- MicroRNA in disease regulation 5
-
- Cancer Cells and Metastasis 5
-
- Virus-based gene therapy research 4
- Journals
- Journal of Controlled Release (4 papers)International Journal of Pharmaceutics (4 papers)Journal of Nanobiotechnology (4 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Sanjun Shi
65 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Biomaterials 768
- Pharmaceutical Science 239
- Rehabilitation 157
- Biomedical Engineering 876
- Molecular Medicine 92
Countries citing papers authored by Sanjun Shi
This map shows the geographic impact of Sanjun Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanjun Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanjun Shi more than expected).
Fields of papers citing papers by Sanjun Shi
This network shows the impact of papers produced by Sanjun Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanjun Shi. The network helps show where Sanjun Shi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sanjun Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 4 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 5 | |
| 6 | 2024 | 9 | |
| 7 | 2023 | 42 | |
| 8 | 2023 | 36 | |
| 9 | 2023 | 11 | |
| 10 | 2023 | 2 | |
| 11 | 2023 | 28 | |
| 12 | 2023 | 51 | |
| 13 | 2021 | 32 | |
| 14 | 2021 | 75 | |
| 15 | 2019 | 47 | |
| 16 | 2019 | 239 | |
| 17 | 2019 | 24 | |
| 18 | 2013 | 20 | |
| 19 | 2011 | 104 | |
| 20 | Biological characteristics of onion leaf blight fungus | 1991 | 1 |
About Sanjun Shi
Sanjun Shi is a scholar working on Biomaterials, Pharmaceutical Science, Rehabilitation, Cancer Research and Molecular Biology, having authored 66 papers that have together received 2.9k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (14 papers), Advanced biosensing and bioanalysis techniques (11 papers), Nanoplatforms for cancer theranostics (9 papers), Nanoparticle-Based Drug Delivery (7 papers), Wound Healing and Treatments (5 papers), MicroRNA in disease regulation (5 papers), Cancer Cells and Metastasis (5 papers) and Virus-based gene therapy research (4 papers). The work is most often cited by research in Biomaterials (768 citations), Pharmaceutical Science (239 citations), Rehabilitation (157 citations), Biomedical Engineering (876 citations) and Molecular Medicine (92 citations). Sanjun Shi has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Tao Gong, Xun Sun, Zhirong Zhang, Wei Tao, Na Kong, Xiaoyuan Ji, Junqing Wang, Yuling Xiao, Jinjun Shi and Chenwen Li. Their work appears in journals such as Journal of Controlled Release, International Journal of Pharmaceutics, Journal of Nanobiotechnology, Acta Pharmaceutica Sinica B and Molecular Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.